Logo image of CHCT

COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Earnings & Estimates

USA - New York Stock Exchange - NYSE:CHCT - US20369C1062 - REIT

16.85 USD
-0.05 (-0.3%)
Last: 1/12/2026, 8:04:00 PM
16.85 USD
0 (0%)
After Hours: 1/12/2026, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CHCT revenue by date.CHCT revenue by date.
97.68M
7.84%
112.845M
15.53%
115.786M
2.61%
123.86M
6.97%
131.27M
5.98%
142.66M
8.68%
165.6M
16.08%
184.86M
11.63%
205.1M
10.95%
EBITDA
YoY % growth
CHCT ebitda by date.CHCT ebitda by date.
66.21M
4.58%
64.794M
-2.14%
73.894M
14.04%
90.772M
22.84%
98.101M
8.07%
106.95M
9.02%
N/AN/AN/A
EBIT
YoY % growth
CHCT ebit by date.CHCT ebit by date.
33.87M
2.92%
25.101M
-25.89%
31.116M
23.96%
26.991M
-13.26%
36.881M
36.64%
48.264M
30.86%
55.716M
15.44%
62.633M
12.41%
69.205M
10.49%
Operating Margin
CHCT operating margin by date.CHCT operating margin by date.
34.67%22.24%26.87%21.79%28.10%33.83%33.64%33.88%33.74%
EPS
YoY % growth
CHCT eps by date.CHCT eps by date.
0.82
-4.65%
0.18
-78.05%
0.21
16.67%
-0.24
-216.57%
0.48
295.83%
0.60
25.53%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.11
180.50%
0.10
240.00%
0.12
148.96%
0.12
308.00%
0.13
18.18%
0.14
40.00%
0.15
25.00%
0.15
25.00%
0.16
23.08%
Revenue
Q2Q % growth
31.665M
8.08%
32.518M
8.11%
32.875M
9.12%
33.383M
7.39%
33.917M
7.11%
34.405M
5.80%
34.989M
6.43%
35.575M
6.57%
36.127M
6.52%
EBITDA
Q2Q % growth
23.51M
-53.89%
23.696M
25.49%
24.248M
1.52%
24.801M
-41.40%
25.355M
7.85%
25.908M
9.33%
26.461M
9.13%
27.014M
8.92%
27.567M
8.72%
EBIT
Q2Q % growth
8.411M
2.49%
10.509M
32.36%
10.385M
403.64%
10.643M
10.91%
10.94M
30.07%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.03
-25.00%
0.08-0.05-63.24%
Q2 2025
Q2Q % growth
-0.25
-1,350.00%
-0.13-0.12-88.54%
Q1 2025
Q2Q % growth
0.03
-72.73%
0.07-0.04-57.98%
Q4 2024
Q2Q % growth
0.04
-73.33%
0.07-0.03-43.98%
Q3 2024
Q2Q % growth
0.04
-63.64%
0.07-0.03-43.98%
Q2 2024
Q2Q % growth
0.02
-91.67%
0.15-0.13-86.93%
Q1 2024
Q2Q % growth
0.11
134.38%
0.18-0.07-40.09%
Q4 2023
Q2Q % growth
0.15
-21.05%
0.150.00-1.96%
Q3 2023
Q2Q % growth
0.11
-47.62%
0.25-0.14-55.98%
Q2 2023
Q2Q % growth
0.24
14.29%
0.210.0312.04%
Q1 2023
Q2Q % growth
-0.32
-252.38%
0.24-0.56-230.72%
Q4 2022
Q2Q % growth
0.19
-17.39%
0.25-0.06-23.97%
Q3 2022
Q2Q % growth
0.21
5.00%
0.25-0.04-15.97%
Q2 2022
Q2Q % growth
0.21
-4.55%
0.23-0.02-10.49%
Q1 2022
Q2Q % growth
0.21 0.25-0.04-15.97%
Q4 2021
Q2Q % growth
0.23
9.52%
0.26-0.02-9.80%
Q3 2021
Q2Q % growth
0.20
-9.09%
0.26-0.05-21.57%
Q2 2021
Q2Q % growth
0.22
15.79%
0.24-0.02-8.87%
Q1 2021
Q2Q % growth
0.21
16.67%
0.24-0.03-13.01%
Q4 2020
Q2Q % growth
0.21 0.23-0.02-10.49%
Q3 2020
Q2Q % growth
0.22 0.220.00-0.83%
Q2 2020
Q2Q % growth
0.19 0.20-0.01-5.29%
Q1 2020
Q2Q % growth
0.18 0.180.00-1.96%
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
31.086M
4.88%
31.172M-86K-0.28%
Q2 2025
Q2Q % growth
30.128M
9.49%
30.896M-768K-2.49%
Q1 2025
Q2Q % growth
30.078M
2.54%
30.235M-157K-0.52%
Q4 2024
Q2Q % growth
29.298M
0.60%
30.405M-1.107M-3.64%
Q3 2024
Q2Q % growth
29.639M
3.15%
30.117M-478K-1.59%
Q2 2024
Q2Q % growth
27.516M
-1.06%
30.984M-3.468M-11.19%
Q1 2024
Q2Q % growth
29.333M
7.94%
30.219M-886K-2.93%
Q4 2023
Q2Q % growth
29.124M
14.93%
30.356M-1.232M-4.06%
Q3 2023
Q2Q % growth
28.735M
15.82%
29.444M-709K-2.41%
Q2 2023
Q2Q % growth
27.81M
15.63%
28.423M-613K-2.16%
Q1 2023
Q2Q % growth
27.176M
15.74%
27.105M71K0.26%
Q4 2022
Q2Q % growth
25.34M
9.04%
26.141M-801K-3.06%
Q3 2022
Q2Q % growth
24.81M
6.71%
24.916M-106K-0.43%
Q2 2022
Q2Q % growth
24.05M
5.99%
24.4M-350K-1.43%
Q1 2022
Q2Q % growth
23.48M
9.72%
24.288M-808K-3.33%
Q4 2021
Q2Q % growth
23.24M
15.51%
24.126M-886K-3.67%
Q3 2021
Q2Q % growth
23.25M
20.22%
23.133M117K0.51%
Q2 2021
Q2Q % growth
22.69M
24.12%
22.374M316K1.41%
Q1 2021
Q2Q % growth
21.4M
19.29%
21.14M260K1.23%
Q4 2020
Q2Q % growth
20.12M 20.28M-160K-0.79%
Q3 2020
Q2Q % growth
19.34M 19.037M303K1.59%
Q2 2020
Q2Q % growth
18.28M 18.65M-370K-1.98%
Q1 2020
Q2Q % growth
17.94M 18.002M-62K-0.34%
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 37.5% 0% 0%
Revenue0% 0.63% 0% 0.23%